AGNC Investment Corp. heads into its Monday earnings report with two fresh analyst downgrades landing the same morning and short interest at a decade-defining high for the stock.
Options traders have turned notably more defensive. The put/call ratio has climbed to 1.16, roughly 1.6 standard deviations above its 20-day average of 0.975. That reading has drifted steadily higher since late June, when the PCR was running below 0.85, pointing to a clear shift in hedging demand as the print approaches. The stock itself has retraced some of its monthly gain — up 6.25% in a month but off 1.8% on Thursday — closing at $11.22 while peers NLY and DX both added more than 1% on the same session.
Short interest deserves attention here. Bears hold 10% of the free float short, and that position jumped roughly 9% in a single week — the sharpest weekly build in the ORTEX history shown. The ORTEX short score has risen to 70.5, near its six-month peak and well above comparable mortgage REITs such as , where the equivalent score sits around 34. Borrow availability remains relatively loose at around 91% — meaning there are nearly as many shares available to lend as are already borrowed — so there is no mechanical constraint preventing further short-side accumulation ahead of the report.
The analyst community moved decisively this morning. JP Morgan downgraded AGNC from Overweight to Neutral, raising its price target to $12 even as it pulled its positive rating — a classic "upgrade the target, exit the conviction" move. Compass Point simultaneously downgraded to Neutral at $11.50. Those actions bring the consensus to a firm Hold, with just one Buy remaining among 13 rated analysts. Piper Sandler kept its lone Overweight at $12 in early July, the only voice still making a constructive case at current levels. Bulls point to last quarter's tangible book value beat — up 6% quarter-on-quarter to $8.28 per share, aided by tightening mortgage spreads and an $785 million portfolio fair value gain — as evidence the agency MBS environment remains supportive. Bears counter that net spreads compressed to 1.78% from 2.01%, hedging costs are rising as low-cost swaps roll off, and the ORTEX EPS surprise factor score sits at just the 8th percentile, suggesting the company rarely beats on the bottom line.
Insider activity adds a cautionary footnote. The CEO sold roughly 193,000 shares across three days in late April at prices around $11. The CFO and two directors also sold in May. Net insider activity over the past 90 days amounts to roughly 1.27 million shares sold for approximately $14 million in aggregate proceeds — a consistent pattern of reduction at prices near where the stock trades today.
Monday's print will test whether the book value momentum from Q1 has continued into Q2, and whether AGNC can demonstrate spread income resilient enough to satisfy a Street that has just largely stepped to the sidelines.
See the live data behind this article on ORTEX.
Open AGNC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
